Literature DB >> 12076507

A review of animal models for the study of arsenic carcinogenesis.

Jian Ping Wang1, Lixia Qi, Michael R Moore, Jack C Ng.   

Abstract

As inorganic arsenic is a proven human carcinogen, significant effort has been made in recent decades in an attempt to understand arsenic carcinogenesis using animal models, including rodents (rats and mice) and larger mammals such as beagles and monkeys. Transgenic animals were also used to test the carcinogenic effect of arsenicals, but until recently all models had failed to mimic satisfactorily the actual mechanism of arsenic carcinogenicity. However, within the past decade successful animal models have been developed using the most common strains of mice or rats. Thus dimethylarsinic acid (DMA), an organic arsenic compound which is the major metabolite of inorganic arsenicals in mammals, has been proven to be tumorigenic in such animals. Reports of successful cancer induction in animals by inorganic arsenic (arsenite and arsenate) have been rare, and most carcinogenetic studies have used organic arsenicals such as DMA combined with other tumor initiators. Although such experiments used high concentrations of arsenicals for the promotion of tumors, animal models using doses of arsenicals species closed to the exposure level of humans in endemic areas are obviously the most significant. Almost all researchers have used drinking water or food as the pathway for the development of animal model test systems in order to mimic chronic arsenic poisoning in humans; such pathways seem more likely to achieve desirable results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076507     DOI: 10.1016/s0378-4274(02)00086-3

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  14 in total

1.  p27 suppresses arsenite-induced Hsp27/Hsp70 expression through inhibiting JNK2/c-Jun- and HSF-1-dependent pathways.

Authors:  Jinyi Liu; Dongyun Zhang; Xiaoyi Mi; Qing Xia; Yonghui Yu; Zhenghong Zuo; Wei Guo; Xuewei Zhao; Jia Cao; Qing Yang; Angela Zhu; Wancai Yang; Xianglin Shi; Jingxia Li; Chuanshu Huang
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

2.  Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure.

Authors:  Matthew O Gribble; Wan-Yee Tang; Yan Shang; Jonathan Pollak; Jason G Umans; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Eliseo Guallar; Shelley A Cole; M Daniele Fallin; Ana Navas-Acien
Journal:  Arch Toxicol       Date:  2013-10-24       Impact factor: 5.153

Review 3.  From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia.

Authors:  Sai-Juan Chen; Guang-Biao Zhou; Xiao-Wei Zhang; Jian-Hua Mao; Hugues de Thé; Zhu Chen
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

4.  Developmental Windows of Susceptibility to Inorganic Arsenic: A Survey of Current Toxicologic and Epidemiologic Data.

Authors:  P A Bommarito; R C Fry
Journal:  Toxicol Res (Camb)       Date:  2016-09-16       Impact factor: 3.524

5.  Motion-artifact-free in vivo imaging utilizing narcotized avian embryos in ovo.

Authors:  Alexander Heidrich; Lydia Würbach; Thomas Opfermann; Hans Peter Saluz
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

6.  Developmental exposure to 50 parts-per-billion arsenic influences histone modifications and associated epigenetic machinery in a region- and sex-specific manner in the adult mouse brain.

Authors:  Christina R Tyler; Alexander K Hafez; Elizabeth R Solomon; Andrea M Allan
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-17       Impact factor: 4.219

7.  c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells.

Authors:  Dongyun Zhang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-14       Impact factor: 4.219

Review 8.  Long-Term Health Effects and Underlying Biological Mechanisms of Developmental Exposure to Arsenic.

Authors:  Lisa Smeester; Rebecca C Fry
Journal:  Curr Environ Health Rep       Date:  2018-03

9.  Pentavalent methylated arsenicals are substrates of human AQP9.

Authors:  Joseph R McDermott; Xuan Jiang; Lauren C Beene; Barry P Rosen; Zijuan Liu
Journal:  Biometals       Date:  2009-10-04       Impact factor: 2.949

10.  Arsenic detoxification potential of aox genes in arsenite-oxidizing bacteria isolated from natural and constructed wetlands in the Republic of Korea.

Authors:  Jin-Soo Chang; In-Ho Yoon; Ji-Hoon Lee; Ki-Rak Kim; Jeongyi An; Kyoung-Woong Kim
Journal:  Environ Geochem Health       Date:  2009-06-23       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.